Other

Novartis to swallow German cancer-drug maker

Swiss pharmaceutical giant Novartis said this week it had agreed to buy German biotech firm MorphoSys for 2.7 billion euros ($2.9 billion), giving it access to a new blood cancer treatment.

page 3 from 40